Inosan Biopharma

OUR MISSION

We believe that no one should suffer or die as a consequence of animal envenoming. For this reason, we have developed a unique and original platform to make safe, effective, and non-cold chain dependent antivenoms available at a fair price.

We are eager to be part of the solution. We work close to patients along with the medical community, governments, and many international organizations and institutions in order to improve the access to antivenoms and the care for people affected by animal envenoming.

We currently distribute and commercialize our products mainly in Africa and Middle East and we are developing new antivenoms for other regions.

We perform our mission passionately and committed to the integrity wherever we operate. We reflect these values in our products, services, and communication while interacting with people.

Our strategy and products are aligned with the WHO plan to reduce the effects of animal envenoming.

OUR PRODUCTS

At Inosan Biopharma we develop and distribute
the latest generation antivenoms that meet the
highest manufacturing standards

Broad regional coverage of medically important species
Highly purified
High neutralizing capacity with low total protein content
No preservatives
Injectable lyophilizates

Inoserp^TM
PAN-AFRICA

Is a polyvalent equine antivenom specifically indicated for the treatment of sub-Saharan African snake bites. It is a sterile, highly purified lyophilized preparation of equine F(ab´)₂ immunoglobulin fragments neutralizing with high specificity the venoms of the following species: Viperidae: Echis ocellatus, Echis leucogaster, Echis pyramidum, Bitis arietans, Bitis rhinoceros, Bitis nasicornis, Bitis gabonica; and Elapidae: Dendroaspis polylepis, Dendroaspis viridis, Dendroaspis angusticeps, Dendroaspis jamesoni, Naja nigricollis, Naja melanoleuca, Naja haje, Naja pallida, Naja nubiae, Naja katiensis and Naja senegalensis.

Inoserp^TM
MENA

Is a polyvalent equine antivenom specifically indicated for the treatment of sub- Middle East and North African snake bites. It is a sterile, highly purified lyophilized preparation of equine F(ab´)₂ immunoglobulin fragments neutralizing with high specificity the venoms of the following species: Viperidae: Bitis arietans, Cerastes cerastes, Cerastes gasperettii, Cerastes vipera, Daboia deserti, Daboia mauritanica, Daboia palaestinae, Echis carinatus sochureki, Echis coloratus, Echis khosatzkii, Echis leucogaster, Echis megalocephalus, Echis omanensis, Echis pyramidum, Macrovipera lebetina obtusa, Macrovipera Iebetina transmediterranea, Macrovipera Iebetina turanica, Montivipera bornmuelleri, Montivipera raddei kurdistanica, Pseuocerastes fieldi, Pseudocerastes persicus, Vipera latastei and Elapidae: Naja haje, Naja nubiae, Naja pallida and Walterinnesia aegyptia.

Inoscorpi^TM
MENA

Is a polyvalent equine antivenom specifically indicated for the treatment of Middle East and North African scorpion stings. It is a sterile, highly purified lyophilized preparation of equine F(ab´)₂ immunoglobulin fragments neutralizing with high specificity the venoms of the following species: Androctonus australis, Androctonus mauritanicus, Androctonus crassicauda, Androctonus amourexi, Androctonus bicolor, Buthus occitanus, Buthus mardochei, Leiurus quinquestriatus quinquestriatus, Leiurus quinquestriatus hebraeus, Buthus Tunetanus.

Technology driven solutions for the present and constantly evolving for the future.

At Inosan Biopharma, we have transformed antiserum to very pure antigen-binding immunoglobulin fragments with high neutralizing potency in full compliance with international GMPs requirements.

THE TEAM

Juan López de Silanes Blanco

CEO & Founder

Juan López de Silanes y Pérez

Chairman of the board & Founder

Beatriz López de Silanes Blanco

General Counsel & Chief
Compliance Officer

An independent family company.
We care for people, especially those affected by animal envenoming all around the world.

Raúl Soria

VP & COO

Always close to your community sharing our knowledge and training the future experts

Venom Week

March 4-7, 2020

Gainesville

ACAME

March 26-28, 2020

Ouagadougou (Burkina Faso)

Venom & Toxins

August 25 & 26, 2020

Oxford (UK)

ASV congress

Dec 2-5, 2020

Douala (Cameroon): the congress of the
African Society of Venimology

PROJECTS CLOSEST TO OUR HEARTS

Snakebites are ‘neglected’ health crisis in Africa

Snakebites kill tens of thousands of Africans a year. Now, an antivenom shortage is spurring global experts to collaborate on treatment and prevention.

Inosan Biopharma

Since our founding we've been working hand by hand with global institutions to bring solutions to communities affected by animal envenoming.

Asclepius Snakebite Foundation

Huge thank you to Inosan Biopharma for donating 200 vials of Inoserp Panafrica polyvalent antivenom to the Asclepius Snakebite Foundation

WHAT´S NEW?

Snakebites are ‘neglected’ health crisis in Africa

Snakebites kill tens of thousands of Africans a year. Now, an antivenom shortage is spurring global experts to collaborate on treatment and prevention.

Inosan Biopharma at the IST 2019

The world in which Inosan Biopharma was created presented a challenge: many pharmaceutical companies.

THE REALITY OF SNAKEBITES – TIME IS TISSUE

With at least 600,000 people worldwide killed or permanently disabled each year, snakebites are the biggest public health crisis that no one has heard of

UCSF Fresno Doctor Studies Venomics for Snakebite Treatment

Ever since he was a little boy, reptiles have fascinated UCSF Fresno emergency physician and medical toxicologist Nicklaus Brandehoff, MD

LANCEMENT D’UNE ÉTUDE AU CAMEROUN POUR ÉVALUER LES SÉRUMS ANTIVENIMEUX

L’étude « Morsures de serpent au Cameroun : Evaluation de Sérum Antivenimeux en Afrique (ESAA) relevé de données en condition de vie réelle

Poisonous animal bites, a public health problem in Mexico

In the current scenario, accidents caused by poisonous animals are already considered a public health problem in Mexico.

Do's and Don'ts in Case of Ophidic Accident

Do you know what to do if you are bitten by a snake? There are many myths about it and in these two minutes Dr. Luis Eduardo Robles Ortíz, MD.

THE ANTIVENOM COMPANY™

This could be the new Treatment developed in Mexico to neutralize COVID